[Lab] SSA reta — Medutest came back 97.4% against a claimed 96.2%
phase 2. That is the whole post, but I will justify it. Everything else people worry about in c/glp1women is downstream of it. Titration speed, early fullness, the endless dose arguments — most of it resolves if you sort phase 2 out first, and almost nobody does. I say this having got it wrong for 10 months. My A1c…
The glucagon component does different things than dual agonism. The early fullness are not just amplified versions.
the dosing is steep, the constipation reports are real, and nobody knows the human safety yet
triple agonism is glucagon, do not generalise
retatrutide is not approved anywhere for human use, posts must not read as instructions
triple agonism plus glucagon is a different physiological state than GIP/GLP-1 dual
Not to be pedantic but triple agonist and dose escalation are being used interchangeably and they are not interchangeable in real life.
Are you quoting phase 2 or is there phase 3 data now?
triple agonism is phase 2, do not generalise
heart rate and dose escalation need actual measurements, not impressions